Meet us at ACS FALL 18 - 20 August
ODISEI Organoid-based Discovery Platform Introduction
Home » Bio, Art & Culture » ODC 25 Session 08 – The Age of Artificial Organs, Organoids

ODC 25 Session 08 – The Age of Artificial Organs, Organoids

What if we could grow organs to repair ourselves?

What if 50 years from now, you could replace a failing liver with a lab-grown version of your own? Or patch up damaged intestines using a bandage made of your own cells?

These were the kinds of questions posed during the 8th session of ODC 25, a conversation blending cutting-edge science with philosophical reflection and even pop culture.

Read more: ODC 2025 – A Festival of Science, Art & Culture

“If we can replace the damaged parts, will we still feel like the same person?” – A question raised in response to organoid-based body repair.

Hosted by: Park Ji-Young

Featuring:

  • Prof. Sun Woong, Korea University
  • Jin Woo Lee, CEO of 3 PRO TV
  • Dr. Mi Young Son, Director, Korea Research Institute of Bioscience (KRIBB)
  • Eun Hye Lee, CMO, Animal Free Initiative (AFI)
  • Jong Man Yoo, CEO, OrganoidSciences
From Millimeters to Miracles: The Current Landscape

Organoids – miniature versions of human organs grown from stem cells – are already transforming research and regenerative medicine. Though still small (think fingernail-sized), they represent a massive leap.

  • Liver, intestine, and even brain organoids are being used to model diseases and test treatments.
  • Korean biotech company OrganoidSciences is among the first globally to launch clinical trials using organoid-based therapies.
  • Some liver disease patients, previously out of options, are now recovering through cell-based interventions.

“People said it was impossible in 2015. Ten years later, we’re proving it’s not.”
–  CEO Jong-Man Yoo, OrganoidSciences

Brain Organoids That Control Robots?

In one of the session’s most surreal moments, researchers revealed how brain organoids – tiny neural structures – have been wired to communicate with a robot. These lab-grown “mini brains” can respond to stimulation and send directional cues, opening up new frontiers in neuroprosthetics and brain-machine interfaces. 

While we’re still far from sentient machines, the possibilities are staggering.

When Science Catches Up to Sci-Fi

Eun-Hye Lee, a creative industry leader and CMO of AFI, drew vivid parallels between today’s breakthroughs and yesterday’s fiction.

  • The Island (2005) imagined clones raised for spare parts.
  • Mickey 17, Bong Joon-ho’s most recent film, explores printable bodies and backup lives.

“Science in movies is often a narrative tool, but real organoid science forces us to consider the ethics in earnest.” – Eun-Hye Lee, AFI

The blurred line between cinematic imagination and scientific possibility leads to deeper questions: What makes us human? Where is the line we shouldn’t cross?

Can Science Go Too Far?

As with any powerful technology, the potential for misuse raises concern: Could someone build fully functional organs – or even people – behind closed doors?

The panelists were quick to ground the discussion: Real organoid development demands massive collaboration, public funding, and is subject to strict regulation. The sci-fi dystopia of rogue labs isn’t impossible, but it’s far from today’s reality.

Still, imagination drives discovery. And sometimes, fiction serves as warning.

Looking Ahead: Not Organs, but Healing

Organoids may not replace full organs just yet – but they’re already healing tissue, restoring vision, and calming inflammation. Key applications include:

  • Corneal transplants – now in human trials
  • Organoid “bandages” for intestinal injuries
  • Drug screening for personalized therapies

“It’s not about replacing the whole liver. It’s about placing a piece of living tissue – like a patch – that helps the body heal itself.”

Final Thought

In this session, experts didn’t just map the science – they shared a vision: a future where biology, technology, and ethics move together to reshape life itself. Whether you’re a scientist, skeptic, or sci-fi fan, one thing is clear: the future body is already under construction.

Lambda Biologics’ Oncology Solutions: Patient-derived cancer organoid-based drug evaluation service 

Gastric Cancer Organoid | Breast Cancer Organoid | Hepatocarcinoma Cancer Organoid | Pancreatic Cancer Organoid

>> See more 

Subscribe
to the latest updates in the newsletter

Related Solutions

  • Disease Modeling
  • Oncology
  • Organoid
  • Cosmetics
  • OECD TG
  • Zebrafish
  • Bioinfomatics
  • Live&3D Imaging
  • Molecular biology
  • Spatial Biology

Next Articles

There are no further posts.

Connect with Us